BenQ BM Holding (Ticker: 2581 HK) is a China-based private for-profit general hospital group specializing in comprehensive healthcare services. A subsidiary of the Taiwan-listed technology group Qisda Corporation (2352 TT), the company operates two major facilities, Nanjing BenQ Hospital and Suzhou BenQ Hospital. It ranks as the largest private for-profit general hospital group in East China by 2024 revenue. BenQ BM Holding is scheduled to list on the HKEX Main Board on 22 December 2025.

The IPO involves an offering of 67,000,000 shares marketed at a price range of HK$9.34 to HK$11.68 per share. The company aims to raise between HK$625.8 million and HK$782.6 million (approximately US$80.4 million to US$100.6 million). This pricing implies a market capitalization of roughly HK$2.91 billion to HK$3.64 billion (US$374 million to US$468 million).

Reportedly, the company plans to use the majority of proceeds (74.2%) for R&D and product capacity expansion, with the remainder allocated to working capital and strategic acquisitions (17.8%) and brand promotion and business development (8%). The IPO is sponsored by China International Capital Corporation and Citigroup, with a syndicate including CTBC Bank and UOB Kay Hian.